Intravenous Immune Globulin

IVIG is covered when it meets Medicare's general ‘‘reasonable and necessary’’ criteria (SSA §1862(a)(1)(A)) and complies with all related LCD/Policy Article and statutory requirements. Coverage and payment are contingent on proper billing by a licensed dispensing entity, receipt of required written orders (SWO/WOPD), appropriate coding, maintenance of proof of delivery, and adherence to DMEPOS refill/delivery timing and quantity limits (contact ≤30 days before expected end, deliver no sooner than 10 days prior, and dispense no more than a one-month supply).

"IVIG is covered when the product is eligible under a Medicare benefit category, is reasonable and necessary for diagnosis or treatment per Social Security Act §1862(a)(1)(A), and meets all other ap..."

Sign up to see full coverage criteria, indications, and limitations.